A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
Plaque PsoriasisThe main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque psoriasis. Participants will be assigned to one of the 3 study treatments (TAK-279, apremilast (an approved treatment), or a placebo). Participants will be in the study for up to 69 weeks.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
18 and up
Critères de participation
Inclusion Criteria:
1. Plaque psoriasis for at least 6 months.
2. Moderate to severe disease.
3. Candidate for phototherapy or systemic therapy.
Exclusion Criteria:
1. Other forms of psoriasis.
2. History of recent infection.
3. Prior exposure to TAK-279 or active comparator.
Other protocol defined inclusion/exclusion criteria apply.
Lieu de l'étude
Dermatology Research Institute, Inc. - Probity - PPDS
Dermatology Research Institute, Inc. - Probity - PPDSCalgary, Alberta
Canada
Contactez l'équipe d'étude
Wiseman Dermatology Research Inc. - Probity - PPDS
Wiseman Dermatology Research Inc. - Probity - PPDSWinnipeg, Manitoba
Canada
Contactez l'équipe d'étude
DermEffects - Probity - PPDS
DermEffects - Probity - PPDSLondon, Ontario
Canada
Contactez l'équipe d'étude
Oshawa Clinic-117 King St
Oshawa Clinic-117 King StOshawa, Ontario
Canada
Contactez l'équipe d'étude
Canadian Dermatology Centre - Probity - PPDS
Canadian Dermatology Centre - Probity - PPDSToronto, Ontario
Canada
Contactez l'équipe d'étude
Siena Medical Research
Siena Medical ResearchWestmount, Quebec
Canada
Contactez l'équipe d'étude
CaRe Clinic-Red Deer
CaRe Clinic-Red DeerRed Deer, Alberta
Canada
Contactez l'équipe d'étude
Dermatrials Research
Dermatrials ResearchHamilton, Ontario
Canada
Contactez l'équipe d'étude
The Centre for Clinical Trials Inc. - Probity - PPDS
The Centre for Clinical Trials Inc. - Probity - PPDSOakville, Ontario
Canada
Contactez l'équipe d'étude
Dr. S. K. Siddha Medicine Professional Corporation - Probity - PPDS
Dr. S. K. Siddha Medicine Professional Corporation - Probity - PPDSRichmond Hill, Ontario
Canada
Contactez l'équipe d'étude
XLR8 Medical Research - Probity - PPDS
XLR8 Medical Research - Probity - PPDSWindsor, Ontario
Canada
Contactez l'équipe d'étude
Alberta DermaSurgery Centre - Probity - PPDS
Alberta DermaSurgery Centre - Probity - PPDSEdmonton, Alberta
Canada
Contactez l'équipe d'étude
Brunswick Dermatology Centre - Probity - PPDS
Brunswick Dermatology Centre - Probity - PPDSFredericton, New Brunswick
Canada
Contactez l'équipe d'étude
Lynderm Research Inc - Probity - PPDS
Lynderm Research Inc - Probity - PPDSMarkham, Ontario
Canada
Contactez l'équipe d'étude
SKiN Centre for Dermatology - Peterborough - Probity - PPDS
SKiN Centre for Dermatology - Peterborough - Probity - PPDSPeterborough, Ontario
Canada
Contactez l'équipe d'étude
Toronto Research Centre - Probity - PPDS
Toronto Research Centre - Probity - PPDSToronto, Ontario
Canada
Contactez l'équipe d'étude
Skinsense Medical Research - 411 2nd Ave N - Probity - PPDS
Skinsense Medical Research - 411 2nd Ave N - Probity - PPDSSaskatoon, Saskatchewan
Canada
Contactez l'équipe d'étude
VIDA Dermatology - Probity - PPDS
VIDA Dermatology - Probity - PPDSEdmonton, Alberta
Canada
Contactez l'équipe d'étude
Lima's Excellence In Allergy And Dermatology Research (Leader) Inc. - Probity - PPDS
Lima's Excellence In Allergy And Dermatology Research (Leader) Inc. - Probity - PPDSHamilton, Ontario
Canada
Contactez l'équipe d'étude
DermEdge Research - Probity - PPDS
DermEdge Research - Probity - PPDSMississauga, Ontario
Canada
Contactez l'équipe d'étude
Centre For Dermatology and Cosmetic Surgery - Probity - PPDS
Centre For Dermatology and Cosmetic Surgery - Probity - PPDSRichmond Hill, Ontario
Canada
Contactez l'équipe d'étude
Alliance Clinical Trials - Probity - PPDS
Alliance Clinical Trials - Probity - PPDSWaterloo, Ontario
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- Takeda
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT06108544